SHELL ASSET MANAGEMENT CO - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$152
-31.8%
7,809
-0.5%
0.01%
-33.3%
Q1 2023$223
-3.0%
7,852
-0.4%
0.01%
-10.0%
Q4 2022$230
-99.9%
7,880
-17.5%
0.01%0.0%
Q3 2022$252,000
-53.0%
9,556
-20.8%
0.01%
-37.5%
Q2 2022$536,000
-10.1%
12,061
+0.2%
0.02%
+14.3%
Q1 2022$596,000
-15.3%
12,041
-12.9%
0.01%0.0%
Q4 2021$704,000
-8.2%
13,822
+0.5%
0.01%
-17.6%
Q3 2021$767,000
+24.9%
13,751
-4.1%
0.02%
+41.7%
Q2 2021$614,000
+43.8%
14,341
+40.3%
0.01%
+33.3%
Q1 2021$427,000
+76.4%
10,225
+96.9%
0.01%
+80.0%
Q4 2020$242,000
+9.5%
5,1930.0%0.01%0.0%
Q3 2020$221,000
-11.2%
5,1930.0%0.01%
-16.7%
Q2 2020$249,000
+2.5%
5,193
-1.5%
0.01%
-14.3%
Q1 2020$243,000
-24.5%
5,273
-1.5%
0.01%0.0%
Q4 2019$322,000
+3.5%
5,355
-2.5%
0.01%0.0%
Q3 2019$311,000
+1.0%
5,491
-0.8%
0.01%0.0%
Q2 2019$308,000
+7.7%
5,538
-2.3%
0.01%
+16.7%
Q1 2019$286,000
+25.4%
5,6670.0%0.01%0.0%
Q4 2018$228,000
-46.7%
5,667
-8.1%
0.01%
-25.0%
Q3 2018$428,000
-8.4%
6,1670.0%0.01%
-20.0%
Q2 2018$467,000
+37.4%
6,167
-4.4%
0.01%
+42.9%
Q1 2018$340,000
-1.4%
6,4500.0%0.01%0.0%
Q4 2017$345,000
-45.1%
6,450
-38.7%
0.01%
-50.0%
Q3 2017$628,00010,5270.01%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 112,666$1,7770.65%
Smith, Graham & Co., Investment Advisors, LP 273,099$4,306,7710.54%
BRANDES INVESTMENT PARTNERS, LP 1,134,363$17,888,9040.35%
TANG CAPITAL MANAGEMENT LLC 118,857$1,874,3750.26%
Virtus Investment Advisers, Inc. 20,867$329,0730.22%
DENALI ADVISORS LLC 32,300$509,3710.18%
Nebula Research & Development LLC 11,473$180,9290.10%
SCOUT INVESTMENTS, INC. 131,192$1,995,4300.05%
XTX Topco Ltd 15,050$237,3390.04%
PDT Partners, LLC 19,745$311,3790.04%
View complete list of EAGLE PHARMACEUTICALS INC shareholders